In a nutshell This study is looking for patients with diabetes taking insulin to test a mobile app that helps patients understand how blood glucose levels change. The main outcome that will be measured is the average blood glucose level at the beginning versus the end of the study. This study is recruiting in Boston, MA, the US. The details...
Read MoreInsulin delivery method-Multiple daily injections (MDI) Posts on Medivizor
Looking for patients with type 2 diabetes to test an insulin inhaler at mealtimes
In a nutshell This study is examining the effectiveness of insulin inhaler Afrezza at mealtimes for patients with type 2 diabetes (T2D). The main outcome of the study will be the time patients’ blood glucose readings are in the ideal range. This study is recruiting in San Antonio, TX, US. The details T2D is a disease where a...
Read MoreHow safe and effective is the new fast-acting insulin therapy for type 1 diabetes?
In a nutshell This study investigated the safety and effectiveness of a new fast-acting insulin aspart at mealtimes and after meals as compared to traditional mealtime insulin in patients with type 1 diabetes (T1D). The main finding was that the fast-acting insulin aspart effectively controlled blood sugar levels in...
Read MoreContinuous glucose monitoring improves glycemic control in patients with type 1 diabetes
In a nutshell This study investigated the effect of continuous glucose monitoring (CGM) in managing blood sugar levels in patients with type 1 diabetes treated with multiple daily insulin injections. They found CGM resulted in a clinically meaningful improvement in glycemic (blood sugar) control. Some background Glycemic control is critical for...
Read MoreContinuous glucose monitoring in patients with impaired awareness of hypoglycemia
In a nutshell The authors aimed to determine whether continuous glucose monitoring improved glycemia (glucose present in the blood) and prevented severe hypoglycemia events (dangerously low blood sugar levels) compared to self-monitoring of blood sugar levels in patients with impaired awareness of hypoglycemia. The authors concluded that continuous...
Read MoreCan insulin injections become more flexible to suit your lifestyle?
In a nutshell This study compared the efficacy and safety of once-daily insulin degludec (Tresiba), following a rigid or flexible schedule, to once-daily insulin glargine (Lantus). Some background Type 2 diabetes affects millions of patients worldwide, many of whom require daily insulin injections to achieve optimal glycemic control. Long-acting...
Read MoreStill calculating? Leave it to your blood glucose meter
In a nutshell This study investigated the use of an automated bolus advisor and its benefit in controlling blood glucose levels. Some background Individuals with diabetes often require several insulin injections a day in order to control blood glucose levels. The amount of insulin needed with each bolus (each injection) depends on many...
Read More